Literature DB >> 2276737

Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3.

S Hosoe1, H Brauch, F Latif, G Glenn, L Daniel, S Bale, P Choyke, M Gorin, E Oldfield, A Berman.   

Abstract

We studied 25 families with von Hippel-Lindau disease (VHL) to locate VHL more precisely on chromosome 3. We found that VHL was linked to RAF1, confirming previous observations, and to two polymorphic DNA markers, D3S18 and D3S191. Multipoint linkage analysis indicated that the most likely location for VHL was in the interval between RAF1 and D3S18. D3S18 was located at 3p26. Genetic heterogeneity was not detected in this panel of von Hippel-Lindau disease families. The polymorphic markers RAF1, D3S18, and D3S191 should be useful in identifying asymptomatic gene carriers in VHL families and in guiding efforts at gene isolation.

Entities:  

Mesh:

Year:  1990        PMID: 2276737     DOI: 10.1016/0888-7543(90)90249-t

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  30 in total

Review 1.  Von Hippel-Lindau disease.

Authors:  E R Maher; A T Moore
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

Review 2.  The von Hippel-Lindau gene: turning discovery into therapy.

Authors:  Peter E Clark; Michael S Cookson
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Fixed archival tissue. Purify DNA and primers for good PCR yield!

Authors:  G Weirich; M A Hornauer; T Brüning; H Höfler; H Brauch
Journal:  Mol Biotechnol       Date:  1997-12       Impact factor: 2.695

4.  Solid haemangioblastomas of the CNS: a review of 17 consecutive cases.

Authors:  Jens Rachinger; Rolf Buslei; Julian Prell; Christian Strauss
Journal:  Neurosurg Rev       Date:  2008-09-20       Impact factor: 3.042

5.  Genetic mapping of dinucleotide repeat polymorphisms and von Hippel-Lindau disease on chromosome 3p25-26.

Authors:  M A Pericak-Vance; K J Nunes; E Whisenant; D B Loeb; K W Small; J M Stajich; J B Rimmler; L H Yamaoka; D I Smith; H A Drabkin
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

6.  Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.

Authors:  H J Decker; C Neuhaus; A Jauch; M Speicher; T Ried; M Bujard; H Brauch; S Störkel; M Stöckle; B Seliger; C Huber
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

Review 7.  Metabolism of kidney cancer: from the lab to clinical practice.

Authors:  Sunil Sudarshan; Jose A Karam; James Brugarolas; R Houston Thompson; Robert Uzzo; Brian Rini; Vitaly Margulis; Jean-Jacques Patard; Bernard Escudier; W Marston Linehan
Journal:  Eur Urol       Date:  2012-09-28       Impact factor: 20.096

8.  Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3.

Authors:  F Latif; W S Modi; F M Duh; L Schmidt; H Li; L Geil; M L Orcutt; A Heppell-Parton; P H Rabbitts; W M Linehan
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

9.  Detection of germline mutations in the von Hippel-Lindau disease gene by the primer specified restriction map modification method.

Authors:  T Kishida; F Chen; M I Lerman; B Zbar
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

10.  Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.

Authors:  P A Crossey; K Foster; F M Richards; M E Phipps; F Latif; K Tory; M H Jones; E Bentley; R Kumar; M I Lerman
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.